Real-time RNA sensors for diabetes management: assessing the impact of endocrine disruptors on biosensing and point-of-care diagnostics.

Ashara P, Chandra M, Sharma PK, Nurhidayat I, Shah MA

Open source

DOI
10.1080/21691401.2026.2679936
Published
2026 Dec
Container
Artificial cells, nanomedicine, and biotechnology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/21691401.2026.2679936,
  title = {Real-time RNA sensors for diabetes management: assessing the impact of endocrine disruptors on biosensing and point-of-care diagnostics.},
  author = {Ashara P and Chandra M and Sharma PK and Nurhidayat I and Shah MA},
  year = {2026},
  journal = {Artificial cells, nanomedicine, and biotechnology},
  doi = {10.1080/21691401.2026.2679936},
  url = {https://doi.org/10.1080/21691401.2026.2679936}
}

RIS

TY  - JOUR
TI  - Real-time RNA sensors for diabetes management: assessing the impact of endocrine disruptors on biosensing and point-of-care diagnostics.
AU  - Ashara P
AU  - Chandra M
AU  - Sharma PK
AU  - Nurhidayat I
AU  - Shah MA
PY  - 2026
JO  - Artificial cells, nanomedicine, and biotechnology
DO  - 10.1080/21691401.2026.2679936
UR  - https://doi.org/10.1080/21691401.2026.2679936
ER  - 

APA

P, A., M, C., PK, S., I, N., & MA, S. (2026). Real-time RNA sensors for diabetes management: assessing the impact of endocrine disruptors on biosensing and point-of-care diagnostics.. Artificial cells, nanomedicine, and biotechnology. https://doi.org/10.1080/21691401.2026.2679936

Source records